4 Einträge gefunden

1. Chemotherapy-induced neutropenia/febrile neutropenia prophylaxis with biosimilar filgrastim in solid tumors versus hematological malignancies: MONITOR-GCSF study

   1. Ludwig, Heinz
   2. Bokemeyer, Carsten
   3. Aapro, Matti
   4. Boccadoro, Mario
   5. Gascón, Pere
   6. Denhaerynck, Kris
   7. Krendyukov, Andriy

   2019 - Forschungsinformationssystem des UKE
2. Outcomes of chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim (Zarzio®) initiated "same-day" ( 72 h): findings from the MONITOR-GCSF study

   1. Ludwig, Heinz
   2. Gascón, Pere
   3. Bokemeyer, Carsten
   4. Aapro, Matti
   5. Boccadoro, Mario
   6. Denhaerynck, Kris
   7. Krendyukov, Andriy

   2019 - Forschungsinformationssystem des UKE
3. Over- and under-prophylaxis for chemotherapy-induced (febrile) neutropenia relative to evidence-based guidelines is associated with differences in outcomes: findings from the MONITOR-GCSF study

   1. Bokemeyer, Carsten
   2. Gascón, Pere
   3. Aapro, Matti
   4. Ludwig, Heinz
   5. Boccadoro, Mario
   6. Denhaerynck, Kris
   7. Gorray, Michael

   2017 - Forschungsinformationssystem des UKE
4. Chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim in elderly versus non-elderly cancer patients: Patterns, outcomes, and determinants (MONITOR-GCSF study)

   1. Aapro, Matti
   2. Bokemeyer, Carsten
   3. Ludwig, Heinz
   4. Gascón, Pere
   5. Boccadoro, Mario
   6. Denhaerynck, Kris
   7. Gorray, Michael

   2016 - Forschungsinformationssystem des UKE